Service & Suppliers
Filter News
Found 19,869 articles
-
AHF Demands Full Transparency as J&J and FDA Balk at Sharing COVID VAX Trial Info
10/20/2020
Despite a widely-touted recent joint pledge of prudence and caution on vaccine trial safety by nine drug companies working on COVID 19 vaccines, most fall far short on even the most basic transparency
-
Open Orphan/hVIVO Signs Contract with UK Government for the Development of a COVID-19 Human Challenge Study Model
10/20/2020
Open Orphan plc, a rapidly growing specialist CRO pharmaceutical services company, which is the world leader in the testing of vaccines and antivirals using human challenge studies, is pleased to announce the signing of a contract by hVIVO, a subsidiary of Open Orphan, with the UK Government to develop a COVID-19 human challenge study model.
-
Dr. Augusto Sola, Masimo VP of Medical Affairs for Neonatology, Honored by the American Academy of Pediatrics with Pioneer Award
10/19/2020
Dr. Sola Pioneered New Protocol Using Masimo SET® Pulse Oximetry That Dramatically Reduced Blindness and Eye Damage in Neonates
-
Mopec Releases Whitepaper Examining "The Future of Mass Fatality Preparedness"
10/19/2020
Report analyzes lessons learned from the COVID-19 pandemic and advises how to proactively plan for the next crisis
-
Swine Model Study of Hemorrhagic Shock Demonstrates Efficacy Of Biobeat's Wearable Monitoring Device In Comparison To Invasive Arterial Line And Swan-Ganz Catheter Monitoring Methods
10/19/2020
New Peer-Reviewed Study Substantiates Use Of Photoplethysmography-Based (PPG) Device To Help Accurately Monitor Patient Vitals, Even During Significant Hemodynamic Changes
-
Tampa General Hospital Uses BMC Automated Data Solution to Collaborate with Hospitals and Fight COVID-19
10/19/2020
wBMC's Control-M helps Tampa General automate data processes for enhanced health care and coordination
-
Annual drug costs increased $1.25 billion for members with more than $250,000 in annual drug spend - doubling in four years
10/19/2020
Rare disease therapy. One-time gene therapies. High-priced cancer drugs. These are all reasons why a consumer may have drug costs of $250,000 or more annually.
-
LabCorp Launches Quantitative Antibody Test to Assess Effectiveness of COVID-19 Vaccines in Clinical Trials
10/19/2020
Quantitative Test is Used to Assess Immune Response and to Support Other Scientific Research
-
New Data Supports iCAD’s Xoft Brain IORT as Feasible Treatment for Recurrent GlioblastomaNew, Encouraging Results and Overall Patient Survival Numbers to be Presented at European Congress of Neurosurgery
10/19/2020
iCAD, Inc. announced that new, promising clinical results supporting the Xoft® Axxent® Electronic Brachytherapy System® for the treatment of recurrent glioblastoma, will be presented at the European Association of Neurosurgical Societies Virtual Congress, October 19- 21, 2020.
-
Dr. Jan Fritz of NYU Langone Health joins SyntheticMR's Medical Advisory Board
10/19/2020
SyntheticMR welcomes Dr Fritz to their Medical Advisory Board to support their product management with clinical expertise.
-
Hewlett Packard Enterprise Selected to Build Australia’s Most Powerful Supercomputer for Advancing Scientific Research at Pawsey Supercomputing Centre
10/19/2020
Pawsey will gain 30X more compute power and 10X more energy efficiency with advanced supercomputing solutions using the HPE Cray EX supercomputer featuring future AMD EPYC™ CPUs and AMD Instinct™ GPUs
-
Lower total cost of care, hospitalizations, emergency visits associated with greater drug adherence among Medicare Advantage members
10/19/2020
Prime Therapeutics researchers studied hypertension, cholesterol and diabetes medications
-
Bruker Introduces Routine Gradient Spectroscopy and Robust, Industry-Standard PAL® Automation on High-Performance Fourier™ 80 Benchtop FT-NMR System
10/19/2020
Bruker Corporation announces the European launch of the high-performance Fourier™ 80 system, a next-generation, 80 MHz Fourier Transform Nuclear Magnetic Resonance benchtop spectrometer, now with major new capabilities.
-
Physicists Propose New Field of Study Related to Coherent Ising Machine
10/19/2020
NTT Research, Inc., a division of NTT, announced that Dr. Yoshihisa Yamamoto, the Director of its Physics and Informatics Lab, along with colleagues at several academic institutions, has proposed an interdisciplinary research agenda that amounts to a new field of academic study.
-
McKesson’s Board of Directors Elects Linda Mantia as New Independent Director
10/19/2020
McKesson Corporation announced that the McKesson board of directors has elected Linda Mantia as an independent director and member of the board’s Audit and Governance Committees, effective Oct. 19, 2020.
-
Low Vision Resources and Rehabilitation for Retinal Degeneration Patients: A Webinar to Discuss Critical Needs and Opportunities
10/19/2020
The free November 11 webinar for eye care professionals will convene industry experts to discuss the latest in low vision resources and rehabilitation as well as gaps in low vision care.
-
Midatech Pharma PLC Announces Headline Results of MTX110 Phase I DIPG Study
10/19/2020
Midatech Pharma PLC, an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, is pleased to announce encouraging headline results from a Phase I study at the University of California, San Francisco in patients with Diffuse Intrinsic Pontine Glioma .
-
NHI Provides Business Update - Oct 19, 2020
10/19/2020
National Health Investors, Inc. provided a business update regarding its monthly contractual rent collections and average occupancy from its three largest senior housing operators.
-
IPRO to Provide Hospital Quality Improvement Services for the Centers for Medicare & Medicaid Services
10/19/2020
The Centers for Medicare & Medicaid Services has awarded a four-year contract to IPRO to serve as a Hospital Quality Improvement Contractor within its Network of Quality Improvement and Innovation Contractors.
-
Teleflex Announces Third Quarter 2020 Earnings Conference Call Information Live Webcast is scheduled at 8:00 a.m. (ET) on Thursday, October 29, 2020
10/19/2020
Teleflex Incorporated announced that financial results for the third quarter 2020 will be released before market open on Thursday, October 29, 2020.